Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies

作者: C Rosenquist , P Qvist , N Bjarnason , C Christiansen

DOI: 10.1093/CLINCHEM/41.10.1439

关键词: EndocrinologySerum concentrationChemistryInternal medicineMonoclonal antibodyOsteocalcinMicrogramPostmenopausal womenAmino acidCapture antibodySerum samples

摘要: Intact human osteocalcin purified from femoral bones as well tryptic fragments of the intact molecule [amino acids (aa) 1-19, 20-43, and 45-49] were used to raise screen monoclonal antibodies (MAbs). A two-site ELISA for measurement in serum was developed with use these MAbs. MAb recognizing midregion (aa20-43) capture antibody, an NH2 terminus (aa7-19)-specific peroxidase-conjugated detection. Human obtained bone calibration, parallelism observed samples, NH2-terminal midfragments (aa1-43), synthetic osteocalcin. Both inter- intraassay variations < 7%. Serum healthy premenopausal women (n = 49) 18.3 +/- 4.2 micrograms/L (mean SD) 28.6 9.7 early postmenopausal 114). The mean concentration 10) decreased by 10% after 7 days storage at 4 degrees C, whereas reduced 63%. N-MID IRMA measuring monitor effect hormone replacement therapy a retrospective study. significant decrease detected only ELISA.

参考文章(20)
C Rosenquist, M Bonde, C Fledelius, P Qvist, A simple enzyme-linked immunosorbent assay of human osteocalcin Clinical Chemistry. ,vol. 40, pp. 1258- 1264 ,(1994) , 10.1093/CLINCHEM/40.7.1258
Patrick Garnero, Marc Grimaux, Brigitte Demiaux, Corinne Preaudat, Patrick Seguin, Pierre D. Delmas, Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay Journal of Bone and Mineral Research. ,vol. 7, pp. 1389- 1398 ,(2009) , 10.1002/JBMR.5650071206
DAVID M. SLOVIK, CAREN M. GUNDBERG, ROBERT M. NEER, JANE B. LIAN, Clinical Evaluation of Bone Turnover by Serum Osteocalcin Measurements in a Hospital Setting The Journal of Clinical Endocrinology and Metabolism. ,vol. 59, pp. 228- 230 ,(1984) , 10.1210/JCEM-59-2-228
Leonard J. Deftos, Jacqueline G. Parthemore, Paul A. Price, Changes in plasma bone GLA protein during treatment of bone disease. Calcified Tissue International. ,vol. 34, pp. 121- 124 ,(1982) , 10.1007/BF02411221
ARCH K. TAYLOR, SUSAN LINKHART, SUBBURAMAN MOHAN, ROBERT A. CHRISTENSON, FREDERICK R. SINGER, DAVID J. BAYLINK, Multiple Osteocalcin Fragments in Human Urine and Serum as Detected by a Midmolecule Osteocalcin Radioimmunoassay The Journal of Clinical Endocrinology and Metabolism. ,vol. 70, pp. 467- 472 ,(1990) , 10.1210/JCEM-70-2-467
Kenji Hosoda, Susumu Kanzaki, Hiroshi Eguchi, Mamoru Kiyoki, Teizo Yamaji, Yasuko Koshihara, Masataka Shiraki, Yoshiki Seino, Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide. Journal of Bone and Mineral Research. ,vol. 8, pp. 553- 565 ,(2009) , 10.1002/JBMR.5650080506
P. A. Price, S. K. Nishimoto, Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 77, pp. 2234- 2238 ,(1980) , 10.1073/PNAS.77.4.2234
CAREN M. GUNDBERG, JANE B. LIAN, PAUL M. GALLOP, JAMES J. STEINBERG, Urinary γ-Carboxyglutamic Acid and Serum Osteocalcin as Bone Markers: Studies in Osteoporosis and Paget’s Disease The Journal of Clinical Endocrinology and Metabolism. ,vol. 57, pp. 1221- 1225 ,(1983) , 10.1210/JCEM-57-6-1221